DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pumps Market (2023 Edition): Analysis By Product Type (Volumetric, Ambulatory, Insulin, PCA, Syringe Pumps, Others), By Indication, End Use, By Region, By ...

Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe pump or ...

The Food and Drug Administration voiced concerns in a Monday letter that Cardinal Health failed to sufficiently mitigate the risk of incompatibility between its syringes and certain pumps in its ...

Just a week after issuing a notice giving its most serious rating to Cardinal Health’s recall of certain syringes, the FDA has put out a letter to healthcare providers warning that the recall may not ...

The rapid development of pharmaceuticals and prescribed combinations has made administering intravenous drug therapy more involved than ever before, leading to a new generation of “smart pumps” ...

The U.S. FDA advises health care providers (HCPs) to avoid using Monoject syringes distributed by Cardinal Health with syringe pumps or patient-controlled analgesia (PCA) pumps because of ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

During the forecast period, 2024-2029, the Global Infusion Pumps market is expected to grow at a CAGR of 11%. The Global Infusion Pumps Market is expected to generate 39.57 billion by the end of 2029, ...